Validity Test of Wearable Continuous Blood Pressure Measuring System

July 21, 2020 updated by: Yonsei University
  1. Purpose of Research For the feasibility test of a wearable blood pressure measuring device, biometric data of patients in surgical intensive care is simultaneously obtained and stored from the device and a patient monitor.
  2. Overview of Research Design This research is simply to obtain and store the data: 1) invasive arterial blood pressure measured with a patient monitor from one wrist, and 2) multi-wavelength photoplethysmography and pressure signal measured with the developed wearable device from the other wrist.
  3. Medical Device for Clinical Trial Patient monitor (IntelliVue MX700, Philips, NED) and wearable blood pressure measuring device
  4. Target Recruiting Number of Participants Considering the expected patient number in intensive care and 10% dropout rate during the research period, the target recurring number of participants is 220.
  5. Criteria of Participant Inclusion

    1. Adult patient in surgical intensive care of Severance Hospital
    2. Voluntarily agreed to participate the research and not included to the exclusion criteria
  6. Criteria of Participant Exclusion

    1. Patient with occlusive peripheral arterial disease
    2. Patient with cardiovascular disease of serious arrhythmia except atrial fibrillation
    3. Patient administered high-dose of pressor agent over 15 mcg/min
    4. Patient who is not available for measurement of invasive arterial blood pressure
    5. Patient who is not available to wear an wearable device on the wrist
    6. Pregnant woman, minor
  7. Evaluation Parameter

    1. Systolic and diastolic blood pressure, which extracted in mmHg unit from the continuous blood pressure output of patient monitor.
    2. Blood pressure, which estimated by the signal analysis of multi-wavelength photoplethysmography and pressure signal measured with the wearable device.
  8. Data Analysis and Statistical Methods

    1. From the multi-wavelength photoplethysmography and multi-channel pressure signal measured, continuous blood pressure will be estimated through the hemodynamic model and machine learning model.
    2. For the machine learning model, the data obtained will be divided into the training data and evaluation data, with the ratio of 80% and 20%.
    3. In order to evaluate the accuracy of the estimated blood pressure, the invasive arterial blood pressure will be considered as the reference blood pressure. Between the estimated blood pressure and the reference blood pressure, the correlation and root mean square error (RMSE) will be calculated.

Study Overview

Status

Unknown

Detailed Description

  1. Recruit participants.
  2. Explain the research purpose and details, and then have the participant sign the consent form.
  3. Before starting the measurement, gather the participant's information such as age, length, and weight.
  4. Measure noninvasive blood pressure in both arms. Compared to the blood pressure in the arm where inserted a catheter, confirm if difference of systolic or diastolic blood pressure in the other side of arm is not more than 10%.
  5. Wear the wearable device on the opposite wrist from the catheter-inserted.
  6. For 10 minutes, simultaneously obtain the data: 1) invasive arterial blood pressure measured with a patient monitor, and 2) multi-wavelength photoplethysmography and pressure signal measured with the developed wearable device.
  7. For accuracy of data acquisition, repeat twice the procedure 5-7 by performing it in the morning and in the afternoon with the 5 hours interval.

Study Type

Observational

Enrollment (Anticipated)

220

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of
        • Recruiting
        • Yonsei University College of Medicine, Department of Anesthesiology and Pain Medicine
        • Contact:
        • Principal Investigator:
          • Jeongmin Kim
        • Sub-Investigator:
          • KwanHyung Kim

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients in surgical intensive care

Description

Inclusion Criteria:

  1. Adult patient in surgical intensive care of Severance Hospital
  2. Voluntarily agreed to participate the research and not included to the exclusion criteria

Exclusion Criteria:

  1. Patient with occlusive peripheral arterial disease
  2. Patient with cardiovascular disease of serious arrhythmia except atrial fibrillation
  3. Patient administered high-dose of pressor agent over 15 mcg/min
  4. Patient who is not available for measurement of invasive arterial blood pressure
  5. Patient who is not available to wear an wearable device on the wrist
  6. Pregnant woman, minor

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Subject
Patients in surgical intensive unit

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Title quality of pulsewave
Time Frame: 2 years
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
User Comfortability
Time Frame: 2 years
Abnormal symptoms or discomforts reported in wearing device
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 7, 2020

Primary Completion (Anticipated)

January 1, 2022

Study Completion (Anticipated)

January 1, 2022

Study Registration Dates

First Submitted

February 6, 2020

First Submitted That Met QC Criteria

February 6, 2020

First Posted (Actual)

February 7, 2020

Study Record Updates

Last Update Posted (Actual)

July 23, 2020

Last Update Submitted That Met QC Criteria

July 21, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 1-2019-0080

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patients in Surgical Intensive Care

3
Subscribe